To validate the significance of Mi-2β in regulating the immune microenvironment in human melanoma, the correlation between Mi-2β mRNA levels and those of CD8A and CD8B were first analyzed in melanoma patients collected in The Cancer Genome Atlas (TCGA). The gene discussed is CHD4; the disease is melanoma.